Publication | Open Access

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

ThrombosisHematologyGynecologyHemostasisCoagulopathyBleeding DisorderMedicineAnticoagulantHeavy Menstrual BleedingPhase 3Tranexamic Acid